LIN28A and cancer: In fact, in many cancers, high expression of the RNA-binding protein LIN28 is responsible for a global post-transcriptional downregulation of let-7, leading to an increase in different oncogenic targets (MYC, RAS, HMGA2, and others) and promoting tumorigenesis and cancer progression [43].